Breakage and fusion of the TEL (ETV6) gene immature B lymphocytes induced by apoptogenic signals

Blood

Volumn 97, Issue 3, 2001, Pages 737-743

  Eguchi Ishimae, Minenori ^a   Eguchi, Mariko ^b   Ishii, Eiichi ^b   Miyazaki, Sumio ^b   Ueda, Kazuhiro ^b   Kamada, Nanao ^b   Mizutani, Shuki ^b  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

DNA TOPOISOMERASE (ATP HYDROLYSING);

ACUTE LYMPHOBLASTIC LEUKEMIA; APOPTOSIS; ARTICLE; B LYMPHOCYTE ACTIVATION; BLOOD SAMPLING; CELL MATURATION; CHROMOSOME BREAKAGE; CHROMOSOME TRANSLOCATION; DNA STRAND BREAKAGE; ENZYME INHIBITION; GENE FREQUENCY; GENE FUSION; GENE REARRANGEMENT; HUMAN; HUMAN CELL; LEUKEMOGENESIS; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UMBILICAL CORD BLOOD;

EID: 0035254207     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V97.3.737     Document Type: Article

References (36)

1. t(12;21): A new recurrent translocation in acute lymphoblastic leukemia
2. High frequency of t(12;21) in childhood B-lineage acute lymphoblastic leukemia
3. TEL/AML1 fusion resulting from a cryptic t(12;21) is the most common genetic lesion in pediatric ALL and defines a subgroup of patients with an excellent prognosis
4. Secondary leukemias induced by topoisomerase-targeted drugs
5. Site-specific DNA cleavage within the MLL breakpoint cluster region induced by topoisomerase II inhibitors
6. DNA cleavage within the MLL breakpoint cluster region is a specific event which occurs as part of higher-order chromatin fragmentation during the initial stages of apoptosis
7. Prenatal origin of acute lymphoblastic leukaemia in children
8. Protracted and vadable latency of acute lymphoblastic leukemia after TEL-AML1 gene fusion in utero
9. Human acute leukemia cell line with the t(4;11) chromosomal rearrangement exhibits B lineage and monocytic characteristics
10. Establishment of a novel cell line (TS-2) of pre-B acute lymphoblastic leukemia with a t(1;19) not involving the E2A gene
11. Occurrence of TEL-AML1 fusion resulting from (12;21) translocation in human early B-lineage leukemia cell lines
12. Human B lymphocytes immortalization by Epstein-Barr virus in the presence of cyclosporin A
13. Double-strand signal sequence breaks in V(D)J recombination are blunt, 5′-phosphorylated, RAG-dependent and cell cycle regulated
14. Structure of nonhairpin coding-end DNA breaks in cells undergoing V(D)J recombination
15. Apoptotic DNA fragmentation is detected by a semiquantitative ligation-mediated PCR of blunt DNA ends
16. Genomic organization of TEL: The human ETS-variant gene 6
17. Structure and possible mechanisms of TEL-AML1 gene fusions in childhood acute lymphoblastic leukemia
18. Sequence-independent amplification and labeling of yeast artificial chromosomes for fluorescence in situ hybridization
19. Fusion of ETV6 to neurotrophin-3 receptor TRKC in acute myeloid leukemia with t(12;15)(p13;q25)
20. Fluorescence in situ hybridization analysis of 12;21 translocation in Japanese childhood acute lymphoblastic leukemia
21. Minimal residual disease with TEL-AML1 fusion transcript in childhood acute lymphoblastic leukaemia with t(12;21)
22. Chromosome translocation based on illegitimate recombination in human tumors
23. A DNA damage repair mechanism is involved in the origin of chromosomal translocations t(4;11) in primary leukemic cells
24. ETV6-AML1 translocation breakpoints cluster near a purine/pyrimidine repeat region in the ETV6 gene
25. Eukaryotic topoisomerase II preferentially cleaves alternating purine-pyrimidine repeats
26. Alternating purine-pyrimidine tracts may promote chromosomal translocations seen in a variety of human lymphoid tumours
27. Lineage specificity of CBFA2 fusion transcripts
28. Frequent chromosomal translocations induced by DNA double-strand breaks
29. Detection of major bcr-abl gene expression at a very low level in blood cells of some healthy individuals
30. Lymphoma-associated translocation t(14;18) in blood B cells of normal individuals
31. BCL2 translocation frequency rises with age in humans
32. Frequent detection of bcl-2/JH translocations in human blood and organ samples by a quantitative polymerase chain reaction assay
33. BCL-2/JH rearrangements in circulating B cells of healthy blood donors and patients with nonmalignant diseases
34. Partial tandem duplications of the MLL gene are detectable in peripheral blood and bone marrow of heady all healthy donors
35. Fetal origins of the TEL-AML1 fusion gene in identical twins with leukemia
36. Molecular genetics, natural history and the demise of childhood leukaemia